Novartis, GSK team up for $3.6m genetic diversity research in Africa

By PBR Staff Writer

Swiss pharma giant Novartis and British pharmaceuticals company GSK have teamed up to conduct scientific research linking genetic diversity in Africa and its potential impact on response to drug therapeutics.